Identification of immune-mediated neuropathies is important as these disorders often respond to treatment. Patterns of binding of serum M (monoclonal) proteins and autoantibodies correlate with, and may be diagnostic markers for, specific polyneuropathy syndromes. There is evidence that some of these antibodies may play a pathogenic role in polyneuropathy syndromes. Identification of specific immune polyneuropathy syndromes provides guidance regarding immunosuppressive regimens that may be effective treatments.
No takes yet. Share an insight, caveat, or question.
Kornberg et al. (1993) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: